The Latest

  • What Comes After Listening? Making Patient Insights Count
    What Comes After Listening? Making Patient Insights Count

    Patient engagement has become an established capability across biopharma. As organizations gain more experience listening to patients, attention is shifting toward a different question: How should patient insights shape what…

  • What Gets Measured Gets Funded. But Is Patient Engagement Driving Better Outcomes?
    What Gets Measured Gets Funded. But Is Patient Engagement Driving Better Outcomes?

    Patient engagement is being measured more often, but metrics alone do not show why people participate, stay engaged, or report satisfaction. The more important question is what those measures reveal…

  • Why Pharma Is Rethinking Stakeholder Engagement Across the Product Lifecycle
    Why Pharma Is Rethinking Stakeholder Engagement Across the Product Lifecycle

    From trial recruitment to scientific exchange and patient support, stakeholder engagement cuts across clinical development, medical affairs, and commercialization. In partnership with Pharmaceutical Executive, Reverba Global has launched a new…